全球抗生素生产市场 – 2029 年行业趋势及预测

抗生素生产市场分析及规模

根据联合国《2019年人口老龄化报告》，2017年全球60岁以上人口为9.62亿。英国2018年性传播疾病确诊病例为447,694例，较2017年增加5%。此外，2018年报告梅毒病例7,541例，较2017年增加5%，淋病感染病例56,259例，较2017年增加26%。

Data Bridge Market Research 分析，抗生素生产市场规模在 2021 年为 407 亿美元，到 2029 年将飙升至 612.9 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 5.25%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

抗生素生产市场范围和细分

市场定义

A particular class of antimicrobial agent that works against bacteria is an antibiotic. Antibiotic drugs are frequently employed in treating and preventing bacterial infections because they are the most effective type of antibacterial agent.

Antibiotic Production Market Dynamics

Drivers

• Increasing number of patients suffering from infectious diseases

The prevalence of infections and diseases, which is on the rise according to COVID-19, is a serious issue for the healthcare system and will increase the growth rate of the market for treatments.

• Development of extraordinary potential particles

On the other hand, introducing novel sequence treatments and developing extraordinary potential particles are anticipated to create lucrative prospects for business professionals.

• Rise in the geriatric population

The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the antibiotic production market.

Opportunities

Due to a number of factors, including strong initiatives taken by big firms for the expansion of high-level outputs, the market for antibiotic manufacture is anticipated to rise steadily. Other factors influencing market expansion include the increased use of antibiotics in low- and middle-income countries, large investments made by pharmaceutical companies in R&D projects, and an increase in the prevalence of communicable illnesses. Some factors are driving the expansion of the market.

Restraints/Challenges

Despite this, increased drug endorsement costs and improved antibiotic endurance will be anticipated to restrain market expansion.

This antibiotic production market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antibiotic production market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Antibiotic Production Market

Additionally, antibiotics are the subject of intensive research because of the critical necessity for creating medications and treatments for COVID-19. For instance, in a coronavirus (COVID-19) clinical trial conducted in France, Pfizer reported good data for the use of its azithromycin (Zithromax) medication in combination with hydroxychloroquine in March 2020. Similarly, in three cohorts of patients treated with hydroxychloroquine alone, a combination of hydroxychloroquine and azithromycin, and supportive care alone, there was no significant difference in the risks associated with mechanical ventilation, according to a study of 368 patients published in April 2020.

Recent Development

• In October 2020, Arixa Pharmaceuticals Inc., a business focused on creating oral antibiotics of the next generation for drug-resistant Gram-negative infections, will be acquired by Pfizer Inc., according to an announcement made.

Global Antibiotic Production Market Scope

The antibiotic production market is segmented on the basis of drug origin, spectrum of activity, route of administration and class. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Origin

• Natural
• Semisynthetic
• Synthetic

 Spectrum of Activity

• Broad-Spectrum Antibiotic
• Narrow-Spectrum Antibiotic

 Route of Administration

• Oral
• Intravenous
• Others

 Class

• Beta Lactam and Beta Lactamase
• Quinolones
• Macrolides
• Others

Antibiotic Production Market Regional Analysis/Insights

The antibiotic production market is analysed and market size insights and trends are provided by country, drug origin, spectrum of activity, route of administration and class as referenced above.

The countries covered in the antibiotic production market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the antibiotic production market due to the growing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the focus of various established market players to expand their presence in this particular region owed to the existence of lucrative market ground in terms of volume and revenue.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和抗生素生产市场份额分析

抗生素生产市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对抗生素生产市场的关注有关。

抗生素生产市场的一些主要参与者包括：

• 雅培（美国）
• F.Hoffmann-La Roche Ltd（瑞士）
• 艾尔建（爱尔兰）
• 安进公司 (美国)
• 葛兰素史克公司（英国）
• 默克夏普和多姆公司 (美国)
• 诺华公司（瑞士）
• 辉瑞公司（美国）
• 强生私人有限公司（美国）
• Mylan NV（美国）
• Teva Pharmaceutical Industries Ltd（美国）
• 赛诺菲（法国）

SKU-52794